Biotech Values

[DewDiligence]

>I believed this to be true, also, which is why I never thought Abraxane would sell. Turns out this is wrong.<

It’s a matter of degree, of course. Abraxane has a good enough label to pull it off (#msg-23097814).

A drug I’d cite as evidence of the toughness of selling to hospitals is Angiomax. It’s a fine drug, but it costs a lot more than heparin.